|
US12569438B2
(en)
|
2019-07-29 |
2026-03-10 |
Georgia Tech Research Corporation |
Nanomaterials containing constrained lipids and uses thereof
|
|
US12521451B2
(en)
|
2019-11-08 |
2026-01-13 |
Regeneron Pharmaceuticals, Inc. |
CRISPR and AAV strategies for x-linked juvenile retinoschisis therapy
|
|
US12435035B2
(en)
*
|
2020-01-09 |
2025-10-07 |
Guide Therapeutics, Llc |
Nanomaterials
|
|
KR20230017783A
(ko)
|
2020-04-28 |
2023-02-06 |
인텔리아 테라퓨틱스, 인크. |
시험관내 세포 전달 방법
|
|
IL298363A
(en)
|
2020-05-20 |
2023-01-01 |
Flagship Pioneering Innovations Vi Llc |
Immunogenic compositions and uses thereof
|
|
CA3179420A1
(en)
|
2020-05-20 |
2021-11-25 |
Avak Kahvejian |
Coronavirus antigen compositions and their uses
|
|
CA3180101A1
(en)
|
2020-05-29 |
2021-12-02 |
Flagship Pioneering Innovations Vi, Llc |
Trem compositions and methods relating thereto
|
|
CA3182026A1
(en)
|
2020-05-29 |
2021-12-02 |
Flagship Pioneering Innovations Vi, Llc. |
Trem compositions and methods relating thereto
|
|
MX2023000802A
(es)
*
|
2020-07-17 |
2023-02-27 |
Sanofi Pasteur |
Compuestos lipidicos escindibles, composiciones que los contienen y usos de los mismos.
|
|
MX2023002439A
(es)
|
2020-09-03 |
2023-05-09 |
Flagship Pioneering Innovations Vi Llc |
Composiciones immunogénicas y usos de las mismas.
|
|
JP2023549011A
(ja)
|
2020-09-15 |
2023-11-22 |
ヴァーヴ・セラピューティクス，インコーポレーテッド |
遺伝子編集のための脂質製剤
|
|
JP2023546175A
(ja)
|
2020-10-14 |
2023-11-01 |
ジョージ・メイソン・リサーチ・ファウンデーション・インコーポレイテッド |
脂質ナノ粒子製造の方法及びそれに由来する組成物
|
|
CR20230305A
(es)
|
2020-12-11 |
2023-11-10 |
Intellia Therapeutics Inc |
Polinucleótidos, composiciones y métodos para la edición del genoma que implican desaminación
|
|
MX2023007137A
(es)
*
|
2020-12-21 |
2023-08-28 |
Beam Therapeutics Inc |
Nanomateriales que comprenden acetales unidos a ésteres.
|
|
CN116782913A
(zh)
*
|
2020-12-21 |
2023-09-19 |
比姆医疗股份有限公司 |
包括缩醛的纳米材料
|
|
IL303886A
(en)
|
2020-12-23 |
2023-08-01 |
Flagship Pioneering Inc |
Compositions of modified trems and uses thereof
|
|
KR20230131863A
(ko)
|
2021-01-20 |
2023-09-14 |
빔 테라퓨틱스, 인크. |
나노물질
|
|
IL303845A
(en)
*
|
2021-01-20 |
2023-08-01 |
Beam Therapeutics Inc |
Nanomaterials include a degradable property
|
|
JP2024512669A
(ja)
|
2021-03-31 |
2024-03-19 |
フラグシップ パイオニアリング イノベーションズ ブイ，インコーポレーテッド |
タノトランスミッションポリペプチド及び癌の処置におけるそれらの使用
|
|
CR20230535A
(es)
|
2021-04-17 |
2024-02-16 |
Intellia Therapeutics Inc |
Inhibidores de proteína cinasa dependiente de adn y composiciones y usos de estos
|
|
BR112023021477A2
(pt)
*
|
2021-04-17 |
2024-01-30 |
Intellia Therapeutics Inc |
Composições de nanopartículas lipídicas
|
|
US20240200106A1
(en)
*
|
2021-04-17 |
2024-06-20 |
Intellia Thrapeutics, Inc. |
Lipid nanoparticles compositions
|
|
KR20230162043A
(ko)
*
|
2021-04-28 |
2023-11-28 |
후지필름 가부시키가이샤 |
화합물 또는 그 염, 지질 입자 및 의약 조성물
|
|
KR20240032013A
(ko)
|
2021-06-10 |
2024-03-08 |
인텔리아 테라퓨틱스, 인크. |
유전자 편집을 위한 내부 링커를 포함하는 변형된 가이드 rna
|
|
US20240300891A1
(en)
*
|
2021-07-12 |
2024-09-12 |
University Of Cincinnati |
Ionizable lipids, lipid nanoparticles for mrna delivery and methods of making the same
|
|
WO2023009547A1
(en)
|
2021-07-26 |
2023-02-02 |
Flagship Pioneering Innovations Vi, Llc |
Trem compositions and uses thereof
|
|
JP2024530647A
(ja)
*
|
2021-08-03 |
2024-08-23 |
ヴァーヴ・セラピューティクス，インコーポレーテッド |
標的ｒｎａ送達のための組成物および方法
|
|
CN118317944A
(zh)
|
2021-09-14 |
2024-07-09 |
雷纳嘉德医疗管理公司 |
非环状脂质及其使用方法
|
|
ES2994006T3
(en)
|
2021-09-17 |
2025-01-16 |
Flagship Pioneering Innovations Vi Llc |
Compositions and methods for producing circular polyribonucleotides
|
|
CN113773216B
(zh)
*
|
2021-09-30 |
2022-12-27 |
贵州大学 |
一种长链脂肪酸甘油醇类化合物Rubracin A、制备方法及其应用
|
|
CA3234127A1
(en)
*
|
2021-10-08 |
2023-04-13 |
Suzhou Abogen Biosciences Co., Ltd. |
Lipid compounds and lipid nanoparticle compositions
|
|
JP2024538144A
(ja)
|
2021-10-18 |
2024-10-18 |
フラッグシップ パイオニアリング イノベーションズ シックス，エルエルシー |
ポリリボヌクレオチドを精製するための組成物及び方法
|
|
KR20240090727A
(ko)
|
2021-10-22 |
2024-06-21 |
세일 바이오메디슨스, 인크. |
Mrna 백신 조성물
|
|
EP4426822A2
(en)
|
2021-11-03 |
2024-09-11 |
Intellia Therapeutics, Inc. |
Polynucleotides, compositions, and methods for genome editing
|
|
CN118488834A
(zh)
|
2021-11-23 |
2024-08-13 |
赛欧生物医药股份有限公司 |
细菌源性脂质组合物和其用途
|
|
MX2024006440A
(es)
|
2021-11-24 |
2024-08-19 |
Flagship Pioneering Innovations Vi Llc |
Composiciones inmunogenicas y sus usos.
|
|
EP4436984A1
(en)
|
2021-11-24 |
2024-10-02 |
Flagship Pioneering Innovations VI, LLC |
Coronavirus immunogen compositions and their uses
|
|
AU2022397292A1
(en)
|
2021-11-24 |
2024-05-30 |
Flagship Pioneering Innovations Vi, Llc |
Varicella-zoster virus immunogen compositions and their uses
|
|
JP2024546855A
(ja)
|
2021-12-17 |
2024-12-26 |
フラッグシップ パイオニアリング イノベーションズ シックス，エルエルシー |
変性条件下での環状ｒｎａの濃縮方法
|
|
CA3241488A1
(en)
*
|
2021-12-20 |
2023-06-29 |
Beam Therapeutics Inc. |
Ionizable amine lipids and lipid nanoparticles
|
|
EP4452925A1
(en)
*
|
2021-12-20 |
2024-10-30 |
Beam Therapeutics Inc. |
Nanomaterial comprising diamines
|
|
WO2023122080A1
(en)
|
2021-12-20 |
2023-06-29 |
Senda Biosciences, Inc. |
Compositions comprising mrna and lipid reconstructed plant messenger packs
|
|
EP4452942A1
(en)
*
|
2021-12-20 |
2024-10-30 |
Beam Therapeutics Inc. |
Nanomaterials comprising disulfides
|
|
KR20240117149A
(ko)
|
2021-12-22 |
2024-07-31 |
플래그쉽 파이어니어링 이노베이션스 브이아이, 엘엘씨 |
폴리리보뉴클레오티드를 정제하기 위한 조성물 및 방법
|
|
MX2024007870A
(es)
|
2021-12-23 |
2024-08-15 |
Flagship Pioneering Innovations Vi Llc |
Polirribonucleotidos circulares que codifican polipeptidos antifusogenicos.
|
|
US20250108007A1
(en)
*
|
2021-12-23 |
2025-04-03 |
Suzhou Abogen Biosciences Co., Ltd. |
Lipid compound and lipid nanoparticle composition
|
|
CN120476106A
(zh)
|
2021-12-29 |
2025-08-12 |
江苏恒瑞医药股份有限公司 |
用于递送的脂质和组合物
|
|
CN118829624A
(zh)
*
|
2022-01-17 |
2024-10-22 |
赛诺菲 |
脂质化合物及其用途
|
|
CN114213347B
(zh)
*
|
2022-02-22 |
2022-05-20 |
中国科学院基础医学与肿瘤研究所(筹) |
一种双价可电离脂质化合物、组合物及其应用
|
|
CN114213346B
(zh)
*
|
2022-02-22 |
2022-05-20 |
中国科学院基础医学与肿瘤研究所(筹) |
一种双价可电离脂质化合物、组合物及其应用
|
|
US20250250227A1
(en)
*
|
2022-02-28 |
2025-08-07 |
Shenzhen Shenxin Biotechnology Co., Ltd. |
Amino lipid compound, preparation method therefor, composition thereof and use thereof
|
|
EP4499607A1
(en)
|
2022-03-25 |
2025-02-05 |
Sail Biomedicines, Inc. |
Novel ionizable lipids and lipid nanoparticles and methods of using the same
|
|
CN116354836A
(zh)
*
|
2022-03-25 |
2023-06-30 |
深圳市新合生物医疗科技有限公司 |
阳离子脂质化合物及其制备方法和应用、以及mRNA递送系统
|
|
CN116924923A
(zh)
*
|
2022-04-02 |
2023-10-24 |
科镁信（上海）生物医药科技有限公司 |
阳离子脂质、脂质体及用途
|
|
IL315577A
(en)
*
|
2022-04-05 |
2024-11-01 |
Capstan Therapeutics Inc |
Ionizable cationic lipids and lipid nanoparticles
|
|
JP2025511756A
(ja)
|
2022-04-08 |
2025-04-16 |
フラッグシップ パイオニアリング イノベーションズ セブン，エルエルシー |
ワクチン及び関連する方法
|
|
EP4519243A4
(en)
*
|
2022-05-04 |
2026-04-22 |
Univ Pennsylvania |
Siloxane-based lipids, lipid nanoparticle compositions comprising them, and their methods of use for targeted administration
|
|
US20250295687A1
(en)
|
2022-05-09 |
2025-09-25 |
Flagship Pioneering Innovations Vi, Llc |
Trem compositions and methods of use for treating proliferative disorders
|
|
JP2025516638A
(ja)
|
2022-05-13 |
2025-05-30 |
フラッグシップ パイオニアリング イノベーションズ セブン，エルエルシー |
二本鎖ｄｎａ組成物及び関連する方法
|
|
EP4532713A1
(en)
|
2022-05-27 |
2025-04-09 |
Beam Therapeutics Inc. |
Identification of nanoparticles for preferential tissue or cell targeting
|
|
US20250325492A1
(en)
*
|
2022-06-03 |
2025-10-23 |
University Of Cincinnati |
Ionizable lipids, lipid nanoparticles for mrna delivery and methods of making the same
|
|
CN119384498A
(zh)
|
2022-06-16 |
2025-01-28 |
因特利亚治疗公司 |
用于对细胞进行遗传修饰的方法和组合物
|
|
US20250179492A1
(en)
|
2022-06-22 |
2025-06-05 |
Flagship Pioneering Innovations Vi, Llc |
Compositions of modified trems and uses thereof
|
|
EP4543847A2
(en)
*
|
2022-06-23 |
2025-04-30 |
Turn Biotechnologies, Inc. |
Lipid structures and compositions comprising same
|
|
EP4393511A4
(en)
*
|
2022-07-11 |
2025-04-02 |
Themedium Therapeutics Co., Ltd. |
LIPID COMPOUND AND ITS USE
|
|
AU2023306438A1
(en)
|
2022-07-15 |
2025-02-20 |
Shenzhen Shenxin Biotechnology Co., Ltd. |
Amino lipid compound, preparation method therefor, composition thereof and application thereof
|
|
CN115043790B
(zh)
*
|
2022-07-18 |
2023-09-26 |
贵州大学 |
一种对称杂环化合物、制备方法及其应用
|
|
WO2024019936A1
(en)
|
2022-07-20 |
2024-01-25 |
Beam Therapeutics Inc. |
Nanomaterials comprising triols
|
|
EP4562154A2
(en)
|
2022-07-29 |
2025-06-04 |
Massachusetts Institute of Technology |
COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE SIGNAL REGULATORY PROTEIN ALPHA (SIRPalpha) GENE
|
|
JP2025525778A
(ja)
|
2022-08-01 |
2025-08-07 |
フラッグシップ パイオニアリング イノベーションズ セブン，エルエルシー |
免疫調節タンパク質及び関連方法
|
|
EP4569112A1
(en)
|
2022-08-12 |
2025-06-18 |
Remix Therapeutics Inc. |
Methods and compositions for modulating splicing at alternative splice sites
|
|
AU2023334610A1
(en)
|
2022-08-31 |
2025-03-13 |
Sail Biomedicines, Inc. |
Novel ionizable lipids and lipid nanoparticles and methods of using the same
|
|
KR20250110209A
(ko)
|
2022-09-23 |
2025-07-18 |
엔크로마 바이오, 인크. |
Hbv 유전자 발현의 에피제네틱 조절을 위한 조성물 및 방법
|
|
WO2024077191A1
(en)
|
2022-10-05 |
2024-04-11 |
Flagship Pioneering Innovations V, Inc. |
Nucleic acid molecules encoding trif and additionalpolypeptides and their use in treating cancer
|
|
US20260035338A1
(en)
*
|
2022-10-13 |
2026-02-05 |
Shenzhen Shenxin Biotechnology Co., Ltd. |
Amino lipid compound and lipid nanoparticle for delivering bioactive ingredient
|
|
AU2023372397A1
(en)
|
2022-10-31 |
2025-05-08 |
Flagship Pioneering Innovations Vi, Llc |
Compositions and methods for purifying polyribonucleotides
|
|
EP4615465A1
(en)
|
2022-11-08 |
2025-09-17 |
Flagship Pioneering Innovations VI, LLC |
Compositions and methods for producing circular polyribonucleotides
|
|
EP4615424A1
(en)
|
2022-11-10 |
2025-09-17 |
Sail Biomedicines, Inc. |
Rna compositions comprising lipid nanoparticles or lipid reconstructed natural messenger packs
|
|
EP4619378A2
(en)
*
|
2022-11-16 |
2025-09-24 |
Seawolf Therapeutics, Inc. |
Ionizable lipids and lipid nanoparticle compositions for the delivery of nucleic acids
|
|
JP2025539561A
(ja)
*
|
2022-12-12 |
2025-12-05 |
コリア・インスティテュート・オブ・サイエンス・アンド・テクノロジー |
新規な脂質化合物及びそれを含む脂質ナノ粒子組成物
|
|
TW202430215A
(zh)
|
2022-12-14 |
2024-08-01 |
美商旗艦先鋒創新有限責任（Ｖｉｉ）公司 |
用於將治療劑遞送至骨之組成物和方法
|
|
WO2024138189A2
(en)
|
2022-12-22 |
2024-06-27 |
Intellia Therapeutics, Inc. |
Methods for analyzing nucleic acid cargos of lipid nucleic acid assemblies
|
|
JP2025534494A
(ja)
*
|
2022-12-23 |
2025-10-15 |
グリーン・クロス・コーポレイション |
イオン化可能な脂質及びその使用
|
|
WO2024138115A1
(en)
|
2022-12-23 |
2024-06-27 |
Intellia Theraperutics, Inc. |
Systems and methods for genomic editing
|
|
US20240238473A1
(en)
|
2023-01-09 |
2024-07-18 |
Beth Israel Deaconess Medical Center, Inc. |
Recombinant nucleic acid molecules and their use in wound healing
|
|
WO2024151687A1
(en)
|
2023-01-09 |
2024-07-18 |
Flagship Pioneering Innovations V, Inc. |
Genetic switches and their use in treating cancer
|
|
US20240252520A1
(en)
|
2023-01-09 |
2024-08-01 |
Beth Israel Deaconess Medical Center, Inc. |
Therapeutic agents and their use for treating chronic wounds
|
|
WO2024151583A2
(en)
|
2023-01-09 |
2024-07-18 |
Flagship Pioneering Innovations Vii, Llc |
Vaccines and related methods
|
|
CN121057577A
(zh)
|
2023-01-27 |
2025-12-02 |
赛欧生物医药股份有限公司 |
经修饰的脂质组合物及其用途
|
|
WO2024167885A1
(en)
|
2023-02-06 |
2024-08-15 |
Flagship Pioneering Innovations Vii, Llc |
Immunomodulatory compositions and related methods
|
|
IL322468A
(en)
|
2023-02-13 |
2025-09-01 |
Flagship Pioneering Innovations Vii Llc |
Ionizable lipids containing degradable crosslinkers and lipid carriers for therapeutic compositions
|
|
IL322378A
(en)
|
2023-02-17 |
2025-09-01 |
Flagship Pioneering Innovations Vii Llc |
DNA compositions containing modified cytosine
|
|
JP2026507513A
(ja)
|
2023-02-17 |
2026-03-04 |
フラッグシップ パイオニアリング イノベーションズ セブン，エルエルシー |
修飾されたウラシルを含むｄｎａ組成物
|
|
WO2024192420A1
(en)
|
2023-03-15 |
2024-09-19 |
Flagship Pioneering Innovations Vi, Llc |
Compositions comprising polyribonucleotides and uses thereof
|
|
EP4680276A1
(en)
|
2023-03-15 |
2026-01-21 |
Flagship Pioneering Innovations VI, LLC |
Immunogenic compositions and uses thereof
|
|
EP4683905A1
(en)
*
|
2023-03-22 |
2026-01-28 |
Nanovation Therapeutics Inc. |
Ionizable anionic lipids
|
|
WO2024199282A1
(zh)
*
|
2023-03-28 |
2024-10-03 |
苏州艾博生物科技有限公司 |
脂质化合物和脂质纳米颗粒组合物
|
|
CN120981443A
(zh)
*
|
2023-03-29 |
2025-11-18 |
国立大学法人东北大学 |
具有二硫键的阳离子性脂质
|
|
WO2024216191A1
(en)
|
2023-04-12 |
2024-10-17 |
Flagship Pioneering Innovations Vi, Llc |
Modified trems, compositions, and related methods thereof
|
|
WO2024216128A1
(en)
|
2023-04-12 |
2024-10-17 |
Flagship Pioneering Innovations Vi, Llc |
Trems for use in correction of missense mutations
|
|
WO2024220712A2
(en)
|
2023-04-19 |
2024-10-24 |
Sail Biomedicines, Inc. |
Vaccine compositions
|
|
EP4698150A1
(en)
|
2023-04-19 |
2026-02-25 |
Sail Biomedicines, Inc. |
Delivery of polynucleotides from lipid nanoparticles comprising rna and ionizable lipids
|
|
WO2024220752A2
(en)
|
2023-04-19 |
2024-10-24 |
Sail Biomedicines, Inc. |
Rna therapeutic compositions
|
|
WO2024220746A2
(en)
|
2023-04-21 |
2024-10-24 |
Flagship Pioneering Innovations Vii, Llc |
Rnai agents targeting fatty acid synthase and related methods
|
|
EP4705273A2
(en)
*
|
2023-05-01 |
2026-03-11 |
Factor Bioscience Inc. |
Multivalent ionizable lipid delivery systems
|
|
IL324634A
(en)
|
2023-05-15 |
2026-01-01 |
Nchroma Bio Inc |
Compositions and methods for epigenetic regulation of hbv gene expression
|
|
WO2024238700A1
(en)
|
2023-05-15 |
2024-11-21 |
Chroma Medicine, Inc. |
Compositions and methods for epigenetic regulation of hbv gene expression
|
|
US12311033B2
(en)
|
2023-05-31 |
2025-05-27 |
Capstan Therapeutics, Inc. |
Lipid nanoparticle formulations and compositions
|
|
WO2024258829A1
(en)
|
2023-06-12 |
2024-12-19 |
Flagship Pioneering Innovations Vii, Llc |
Sars-cov-2 vaccine compositions and related methods
|
|
CN121463960A
(zh)
|
2023-06-28 |
2026-02-03 |
上海瑞宏迪医药有限公司 |
一种含有阳离子脂质的药物组合物及其用途
|
|
WO2025006684A1
(en)
|
2023-06-28 |
2025-01-02 |
Flagship Pioneering Innovations Vi, Llc |
Circular polyribonucleotides encoding antifusogenic polypeptides
|
|
CN117024323A
(zh)
*
|
2023-07-21 |
2023-11-10 |
中国科学院基础医学与肿瘤研究所(筹) |
一种可降解、可电离的阳离子脂材及其应用
|
|
AU2024299627A1
(en)
|
2023-07-25 |
2026-01-22 |
Flagship Pioneering Innovations Vii, Llc |
Cas endonucleases and related methods
|
|
WO2025038855A1
(en)
*
|
2023-08-16 |
2025-02-20 |
Beam Therapeutics Inc. |
Ionizable lipids with branched head groups
|
|
WO2025042786A1
(en)
|
2023-08-18 |
2025-02-27 |
Flagship Pioneering Innovations Vi, Llc |
Compositions comprising circular polyribonucleotides and uses thereof
|
|
WO2025049481A1
(en)
|
2023-08-28 |
2025-03-06 |
Intellia Therapeutics, Inc. |
Methods of editing an hla-a gene in vitro
|
|
CN121752723A
(zh)
*
|
2023-08-31 |
2026-03-27 |
正基基因科技有限公司 |
编码crispr相关蛋白的核酸及其应用
|
|
WO2025054236A2
(en)
|
2023-09-06 |
2025-03-13 |
Flagship Pioneering Innovations Vii, Llc |
Sars-cov-2 vaccine compositions and related methods
|
|
WO2025059599A1
(en)
*
|
2023-09-13 |
2025-03-20 |
Tessera Therapeutics, Inc. |
Lipid nanoparticles for delivery of therapeutic payloads to cells
|
|
AU2024344058A1
(en)
|
2023-09-18 |
2026-04-02 |
Flagship Pioneering Innovations Vii, Llc |
Ionizable lipidoid compositions and therapeutic uses thereof
|
|
WO2025072331A1
(en)
|
2023-09-26 |
2025-04-03 |
Flagship Pioneering Innovations Vii, Llc |
Cas nucleases and related methods
|
|
WO2025076127A1
(en)
*
|
2023-10-05 |
2025-04-10 |
Capstan Therapeutics, Inc. |
Constrained ionizable cationic lipids and lipid nanoparticles
|
|
WO2025096807A2
(en)
|
2023-10-31 |
2025-05-08 |
Flagship Pioneering Innovations Vii, Llc |
Novel therapeutic dna forms
|
|
WO2025106670A1
(en)
|
2023-11-14 |
2025-05-22 |
Flagship Pioneering Innovations Vii, Llc |
Ionizable lipidoid compositions and therapeutic uses thereof
|
|
WO2025106930A1
(en)
|
2023-11-17 |
2025-05-22 |
Sail Biomedicines, Inc. |
Circular polyribonucleotides encoding glucagon-like peptide 2 (glp-2) and uses thereof
|
|
WO2025106915A1
(en)
|
2023-11-17 |
2025-05-22 |
Sail Biomedicines, Inc. |
Circular polyribonucleotides encoding glucagon-like peptide 1 (glp-1) and uses thereof
|
|
WO2025111454A1
(en)
*
|
2023-11-21 |
2025-05-30 |
University Of Cincinnati |
Ionizable lipids, lipid nanoparticles for mrna delivery and methods of making the same
|
|
US20250161347A1
(en)
|
2023-11-22 |
2025-05-22 |
Flagship Pioneering Innovations Vii, Llc |
Methods and compositions for treating non-alcoholic fatty liver disease
|
|
WO2025117877A2
(en)
|
2023-12-01 |
2025-06-05 |
Flagship Pioneering Innovations Vii, Llc |
Cas nucleases and related methods
|
|
WO2025128871A2
(en)
|
2023-12-13 |
2025-06-19 |
Renagade Therapeutics Management Inc. |
Lipid nanoparticles comprising coding rna molecules for use in gene editing and as vaccines and therapeutic agents
|
|
WO2025137301A1
(en)
|
2023-12-20 |
2025-06-26 |
Intellia Therapeutics, Inc. |
Methods for rapid engineering of cells
|
|
TW202545974A
(zh)
|
2024-01-26 |
2025-12-01 |
美商旗艦先鋒創新有限責任（Ｖｉｉ）公司 |
免疫受體抑制蛋白及相關方法
|
|
WO2025189064A1
(en)
|
2024-03-08 |
2025-09-12 |
Genzyme Corporation |
Lipid nanoparticles
|
|
WO2025193861A2
(en)
*
|
2024-03-12 |
2025-09-18 |
Tessera Therapeutics, Inc. |
Lipid nanoparticles for delivery of therapeutic payloads to cells
|
|
WO2025194019A1
(en)
|
2024-03-14 |
2025-09-18 |
Flagship Pioneering Innovations Vii, Llc |
Methods for treating liver fibrosis and non-alcoholic fatty liver disease
|
|
WO2025212932A1
(en)
*
|
2024-04-03 |
2025-10-09 |
Intellia Therapeutics, Inc. |
Methods of synthesizing amine lipids
|
|
WO2025217129A1
(en)
*
|
2024-04-08 |
2025-10-16 |
Popvax Private Limited |
Novel lipids for delivery of nucleic acid therapeutics
|
|
WO2025217275A2
(en)
|
2024-04-10 |
2025-10-16 |
Flagship Pioneering Innovations Vii, Llc |
Immune cell targeted compositions and related methods
|
|
WO2025217452A1
(en)
*
|
2024-04-11 |
2025-10-16 |
Capstan Therapeutics, Inc. |
Constrained ionizable cationic lipids and lipid nanoparticles
|
|
WO2025240680A1
(en)
|
2024-05-16 |
2025-11-20 |
Flagship Pioneering Innovations Vii, Llc |
Immunoreceptor inhibitory proteins and related methods
|
|
WO2025240946A1
(en)
|
2024-05-17 |
2025-11-20 |
Intellia Therapeutics, Inc. |
Lipid nanoparticles and lipid nanoparticle compositions
|
|
WO2025245188A2
(en)
|
2024-05-21 |
2025-11-27 |
Flagship Pioneering Innovations Vii, Llc |
Methods of treating liver steatosis and non-alcoholic fatty liver disease
|
|
WO2025245111A1
(en)
|
2024-05-22 |
2025-11-27 |
Flagship Pioneering Innovations Vii, Llc |
Immunoreceptor targeting proteins and related methods
|
|
WO2025250729A1
(en)
*
|
2024-05-29 |
2025-12-04 |
Liberate Bio, Inc. |
Lipid compounds, compositions, and uses thereof
|
|
WO2025250730A1
(en)
*
|
2024-05-29 |
2025-12-04 |
Liberate Bio, Inc. |
Lipid compounds, compositions, and uses thereof
|
|
US20260000702A1
(en)
|
2024-06-26 |
2026-01-01 |
Flagship Pioneering Innovations Vii, Llc |
Therapeutic circular dna forms
|
|
WO2026003582A2
(en)
*
|
2024-06-27 |
2026-01-02 |
Axelyf ehf. |
Lipids and lipid nanoparticles
|
|
WO2026030375A2
(en)
|
2024-07-30 |
2026-02-05 |
Genzyme Corporation |
Lipid nanoparticles and methods of manufacture and use thereof
|
|
WO2026035680A1
(en)
|
2024-08-06 |
2026-02-12 |
Kernal Biologics, Inc. |
Compositions and methods for delivery of agents
|
|
WO2026055543A1
(en)
|
2024-09-06 |
2026-03-12 |
Flagship Pioneering Innovations Vii, Llc |
Modified dna compositions and related methods
|
|
WO2026055547A1
(en)
|
2024-09-06 |
2026-03-12 |
Flagship Pioneering Innovations Vii, Llc |
Dna compositions and related methods
|
|
WO2026064313A1
(en)
|
2024-09-17 |
2026-03-26 |
Flagship Pioneering Innovations Vii, Llc |
Rna compositions and related methods
|